Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKCA | P17252 | 2/20 | 0.60 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.60 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.60 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.60 |
| ▸ | MAPT | P10636 | 2/20 | 0.57 |
| ▸ | CNR2 | P34972 | 2/20 | 0.57 |
| ▸ | CNR1 | P21554 | 2/20 | 0.57 |
| ▸ | FAAH | O00519 | 1/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.57 |
| ▸ | HPGD | P15428 | 1/20 | 0.57 |
| ▸ | DGKA | P23743 | 1/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.53 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.52 |
| ▸ | DAGLA | Q9Y4D2 | 1/20 | 0.49 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.49 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL371296 | 1.00 | PRKCA (0.60) | PRKCAPRKCEPRKCQPRKCDMAPT | |
| SCHEMBL369798 | 1.00 | PRKCA (0.60) | PRKCAPRKCEPRKCQPRKCDMAPT | |
| SCHEMBL26602804 | 1.00 | PRKCA (0.60) | PRKCAPRKCEPRKCQPRKCDMAPT | |
| SCHEMBL369784 | 1.00 | PRKCA (0.60) | PRKCAPRKCEPRKCQPRKCDMAPT | |
| SCHEMBL371275 | 1.00 | PRKCA (0.60) | PRKCAPRKCEPRKCQPRKCDMAPT | |
| SCHEMBL9958966 | 0.91 | MAPT (0.62) | PRKCAPRKCEPRKCQPRKCDMAPT | |
| SCHEMBL369749 | 0.91 | MAPT (0.62) | PRKCAPRKCEPRKCQPRKCDMAPT | |
| SCHEMBL367858 | 0.91 | MAPT (0.62) | PRKCAPRKCEPRKCQPRKCDMAPT | |
| SCHEMBL368664 | 0.91 | MAPT (0.62) | PRKCAPRKCEPRKCQPRKCDMAPT | |
| SCHEMBL16612104 | 0.90 | PRKCA (0.68) | PRKCAPRKCEPRKCQPRKCDMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 89 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116916961-A | Lyotropic liquid crystal phase particles | 皇家墨尔本理工大学 | 2023-10-20 | — | — | CN | claimed |
| US-20220142922-A1 | LIPOSOMAL NANOCONSTRUCTS AND METHODS OF MAKING AND USING THE SAME | THE GENERAL HOSPITAL CORPORATION | 2022-05-12 | — | — | US | claimed |
| CN-106198444-B | Microemulsion and preparation method containing phosphatide, the application in the research aqueous energy in interface | 中国科学院上海应用物理研究所 | 2018-12-04 | — | — | CN | claimed |
| US-20180161272-A1 | LIPOSOMAL NANOCONSTRUCTS AND METHODS OF MAKING AND USING THE SAME | NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR | 2018-06-14 | — | — | US | claimed |
| EP-3302436-A1 | LIPOSOMAL NANOCONSTRUCTS AND METHODS OF MAKING AND USING THE SAME | The General Hospital Corporation (US) | 2018-04-11 | — | — | EP | claimed |
| WO-2016191556-A1 | LIPOSOMAL NANOCONSTRUCTS AND METHODS OF MAKING AND USING THE SAME | THE GENERAL HOSPITAL CORPORATION (US) | 2016-12-01 | — | — | WO | claimed |
| WO-2015036044-A1 | CATIONIC LIPID VEHICLES FOR DELIVERY OF TLR7 AGONISTS FOR SPECIFIC TARGETING OF HUMAN CD14+ MONOCYTES IN WHOLE BLOOD | TELORMEDIX SA (CH) | 2015-03-19 | — | — | WO | claimed |
| US-20150079155-A1 | Cationic Liposomal Drug Delivery System for Specific Targeting of Human CD14+ Monocytes in Whole Blood | BIONEER A/S (DK) | 2015-03-19 | — | — | US | claimed |
| EP-2825158-A1 | CATIONIC LIPOSOMAL DRUG DELIVERY SYSTEM FOR SPECIFIC TARGETING OF HUMAN CD14+ MONOCYTES IN WHOLE BLOOD | Bioneer A/S (DK) | 2015-01-21 | — | — | EP | claimed |
| WO-2013135800-A1 | CATIONIC LIPOSOMAL DRUG DELIVERY SYSTEM FOR SPECIFIC TARGETING OF HUMAN CD14+ MONOCYTES IN WHOLE BLOOD | BIONEER A/S (DK) | 2013-09-19 | — | — | WO | claimed |
| EP-2638896-A1 | Cationic liposomal drug delivery system for specific targeting of human cd14+ monocytes in whole blood | Bioneer A/S (DK) | 2013-09-18 | — | — | EP | claimed |
| EP-4384612-A1 | IMPROVED METHOD FOR SMALL RNA PURIFICATION | Mirnagreen S.r.l. (IT) | 2024-06-19 | — | — | EP | disclosed |
| CN-111867634-B | Enhancement of translocation of micro/nanoparticles across mucus layers using alginate oligomers | 阿尔吉法玛公司 | 2024-06-11 | — | — | CN | disclosed |
| CN-117940563-A | Improved small RNA purification process | 米尔纳格林有限责任公司 | 2024-04-26 | — | — | CN | disclosed |
| CN-117778533-A | Quantitative detection method for nucleic acid in nucleic acid lipid nanoparticle complex | 北京剂泰医药科技有限公司 | 2024-03-29 | — | — | CN | disclosed |
| EP-1937395-A1 | BIOMIMETIC WATER MEMBRANE COMPRISING AQUAPORINS USED IN THE PRODUCTION OF SALINITY POWER | Aquaporin APS (DK) | 2008-07-02 | — | — | EP | disclosed |
| EP-1885477-A2 | MEMBRANE FOR FILTERING OF WATER | Aquaporin APS (DK) | 2008-02-13 | — | — | EP | disclosed |
| WO-2007136404-A2 | LYSOPHOSPHOLIPIDS SOLUBILIZED SINGLE-WALLED CARBON NANOTUBES | CLEMSON UNIVERSITY (US) | 2007-11-29 | — | — | WO | disclosed |
| WO-2007033675-A1 | BIOMIMETIC WATER MEMBRANE COMPRISING AQUAPORINS USED IN THE PRODUCTION OF SALINITY POWER | AQUAPORIN APS (DK) | 2007-03-29 | — | — | WO | disclosed |
| WO-2006122566-A2 | MEMBRANE FOR FILTERING OF WATER | AQUAPORIN APS (DK) | 2006-11-23 | — | — | WO | disclosed |